Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy

Author： Morrow Phuong   Divers Stephen   Provencher Louise   Luoh Shiuh-Wen   Petrella Teresa   Giurescu Marius   Schmelter Thomas   Wang Yao   Hortobagyi Gabriel   Vahdat Linda  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.123, Iss.3, 2010-10, pp. : 837-842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events

By Addison Christina   Bouganim Nathaniel   Hilton John   Vandermeer Lisa   Dent Susan   Amir Eitan   Hopkins Sean   Kuchuk Iryna   Segal Roanne   Song Xinni   Gertler Stan   Mazzarello Sasha   Dranitsaris George   Ooi Daylily   Pond Gregory   Clemons Mark  

Breast Cancer Research and Treatment, Vol. 144, Iss. 3, 2014-04 ,pp. : 615-624

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Study of Capecitabine in Combination With Thalidomide in Patients With Metastatic Breast Cancer

By Burris Howard A.   Jones Suzanne F.   Shipley Dianna   Meluch Anthony A.   Greco F. Anthony   Barton John H.   Yardley Denise A.   Hainsworth John D.  

Cancer Investigation, Vol. 28, Iss. 4, 2010-04 ,pp. : 408-412

Informa Healthcare

Access to resources Recommend Favorite

A Southwest Oncology Group Randomized Phase II Study of Doxorubicin and Paclitaxel as Frontline Chemotherapy for Women with Metastatic Breast Cancer

By Lyman Gary   Green Stephanie   Ravdin Peter   Geyer Charles   Russell Christy   Balcerzak Stanley   Thomas Budd G.   Martino Silvana  

Breast Cancer Research and Treatment, Vol. 85, Iss. 2, 2004-05 ,pp. : 143-150

Springer Publishing Company

Access to resources Recommend Favorite

A phase II double-blinded study to evaluate the efficacy of EW02 in reducing chemotherapy-induced neutropenia in breast cancer

By              

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1793-1798

Spandidos Publications

Access to resources Recommend Favorite

A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

By Johnston S.   Gumbrell L.   Evans T.   Coleman R.   Smith I.   Twelves C.   Soukop M.   Rea D.   Earl H.   Howell A.   Jones A.   Canney P.   Powles T.   Haynes B.   Nutley B.   Grimshaw R.   Jarman M.   Halbert G.   Brampton M.   Haviland J.   Dowsett M.   Coombes R.  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 4, 2004-04 ,pp. : 341-348

Springer Publishing Company

Access to resources Recommend Favorite